Abstract
Some synthetic analogues of the immuno-modulatory agent muramyl dipeptide (MDP), i.e. phthalimido- (LK-511, LK-413, LK-512, LK-423, LK-508), adamantyl- (LK-415, LK-517), 7-oxoaIkyl-(LK-409) desmuramylpeptides were assessed for the tumour necrosis factor (TNF) inducing activity and the ability to modulate TNF production in in vitro phorbol 12-myristate 13-acetate (PMA) & ionomycin stimulated cultures of human peripheral blood mononuclear cells. A kinetic study over a 40-hour period indicated that desmuramyldipeptides were weak TNF inducers compared to romurtide, PMA & ionomycin or lipopolysaccharide. By contrast, they showed the potential to up- or down-regulate the production of TNF evoked by PMA & ionomycin, which was strongly dependent on the time of the stimulation. After 4h of stimulation, the TNF secretion was augmented by LK-508, LK-409 and LK-511, after 18 h by LK-409 and LK-423, and after 40 h by LK-423, LK-511, LK-415 and LK-512. However, LK-517 and LK-512 inhibited the secretion of TNF after the 18-h period.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Published: January 2000
Rights and permissions
About this article
Cite this article
Simčič, S., Wraber, B., Sollner, M. et al. Modulation of tumour necrosis factor production with desmuramyldipeptide analogues. Pflügers Arch 440 (Suppl 1), R064–R066 (2000). https://doi.org/10.1007/s004240000008
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004240000008